Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
F.D.A. Grants Early Access to Promising Drug for Pancreatic Cancer
On May 1, the FDA granted expanded‑access permission for daraxonrasib, an experimental oral drug from Revolution Medicines, allowing patients with previously treated metastatic pancreatic cancer to obtain the therapy outside clinical trials. The drug, taken as three pills daily, has produced the most encouraging survival data ever seen in pancreatic‑cancer studies, targeting the KRAS G12C mutation. The program opens a pathway for desperate patients while the company prepares for a potential full approval. Pancreatic cancer kills over 50,000 Americans annually and has a five‑year survival rate of just 3 percent.
Pacira Q1 2026 Earnings Highlight COO Brendan Teehan's Product Launch Drive
Pacira BioSciences posted a 7% rise in EXPAREL sales to $143.3 M and double‑digit growth for ZILRETTA and ioverao in Q1 2026, attributing the momentum to COO Brendan P. Teehan’s accelerated product launches and expanded sales teams. The company also repurchased...
Mercy Fort Smith Hits $41 Million Goal to Expand Oncology Services
Mercy Fort Smith announced it has reached its $41 million fundraising target for Phase 1 of a major oncology center expansion, aided by a $2 million challenge grant from the Mabee Foundation. The project will double patient capacity and is slated for completion...
Nanjing King‑Friend Biochemical Pharma Posts 4.9% Q1 Revenue Rise to $130 M
Nanjing King‑Friend Biochemical Pharmaceutical Co., Ltd. announced first‑quarter revenue of RMB928.66 million ($130 million), up 4.9% from a year earlier, and profit of RMB89.01 million ($12.5 million). The modest earnings per share of RMB0.05 matched last year, signaling steady profitability amid growing demand for...
New-Onset Loneliness Triggers an Accelerated Drop in Cognitive Health
A new analysis of the English Longitudinal Study of Ageing finds that older adults who first report loneliness experience a rapid acceleration in cognitive decline compared with peers who remain socially connected. Researchers matched 635 newly lonely participants with 1,900...
Regulatory Actions for May 1, 2026
BioWorld released a comprehensive “Regulatory Actions for May 1, 2026” roundup, collating FDA, EMA and other global regulator updates across biopharma, medical technology, and policy domains. The collection links to data snapshots, infographics on digital analysis, and special reports covering topics such...
Accountable Care Leaders Spotlight Next Phase of AI at NAACOS 2026 Spring Meeting
At the NAACOS Spring 2026 meeting in Baltimore, leaders highlighted the transition of AI from pilot projects to operational tools across accountable care organizations. CMS announced a voluntary health‑tech ecosystem that standardizes identity‑verified data exchange and links patient‑facing AI apps...
Pharmacy Deliveries Take Flight: Can Drones Solve America’s Pharmacy Access Gap?
Drone delivery of medications is moving from pilot testing to early operational use across the United States. Federal Aviation Administration Part 135 certification now permits beyond‑visual‑line‑of‑sight flights, enabling compensated, temperature‑controlled shipments to remote patients and health‑system hubs. Studies estimate between 15.8 million...
The Cyborgs Commeth - EP 69 Connor Glass
In this episode, host Ashley Vance talks with Connor Glass, co‑founder and CEO of Phantom Neuro, about the company’s sub‑dermal neural interface that lets amputees control prosthetic limbs using muscle‑derived electrical signals—offering a less invasive alternative to brain‑computer interfaces like...
BrightSpring Aims for Organic Growth Following Amedisys Location Acquisitions
BrightSpring Health Services posted a strong first quarter, with consolidated revenue of $3.64 billion, a 25.6% year‑over‑year increase. The provider services segment, which includes home health and hospice, grew 28% to $422 million, and daily patient census rose 52% to 46,056....
FDA Permits Expanded Access for Investigational Pancreatic Cancer Drug
The FDA issued a “safe to proceed” letter to Revolution Medicines, enabling an expanded access protocol for its experimental pancreatic cancer drug daraxonrasib. The request, received on April 28 and signed on April 30, targets patients with previously treated metastatic pancreatic ductal...
New York Behavioral Health Advocates Rally at Capitol, Win Support of 100+ Legislators for Critical Funding Increase
The Mental Health Association of New York State (MHANYS) and 11 partner organizations launched the “Photo for 4%” campaign, drawing more than 100 state legislators to the Capitol to endorse a targeted 4% inflationary increase in the FY 2026‑27 budget. Advocates...
‘Orchestra of Therapies’ Required for Most SSc Patients
At the 2026 Congress of Clinical Rheumatology East, Dr. Janet Pope emphasized that most systemic sclerosis (SSc) patients require a multi‑modal treatment strategy rather than monotherapy. She highlighted FDA‑approved sotatercept‑csrk for pulmonary arterial hypertension and the effectiveness of combining PDE5...
Stryker Cyberattack ‘Meaningfully’ Impacted Q1
Stryker reported first‑quarter sales of $6 billion, a 2.6% year‑over‑year increase that fell short of its typical 10‑12% growth pace. The slowdown stems from a March 11 cyberattack that shut down ordering, shipping and manufacturing for several weeks, wiping 40,000 laptops...
Redo TAVR: Supra-Annular, Intra-Annular Valves Linked to Comparable Outcomes
A study of 172 redo transcatheter aortic valve replacement (TAVR‑in‑TAVR) procedures from the international PANDORA registry shows comparable one‑year outcomes regardless of whether the initial and second valves are supra‑annular or intra‑annular. The median interval between the index and redo...
Cost Management, Outpatient Unit Helped Tenet Weather Volume Headwinds in Q1
Tenet Healthcare posted $702 million profit on $5.4 billion revenue in Q1, beating Wall Street forecasts despite a 90‑basis‑point drop in acute‑care volumes and a 0.3% dip in outpatient admissions. The operator’s cost‑management program and a strong performance from its ambulatory surgical...
AHA Federal Funding Requests Include Workforce Development for Rural Communities
The American Hospital Association (AHA) has asked Congress to allocate federal funds for 2027 healthcare workforce programs, targeting the chronic staffing gaps in rural America. In letters to House and Senate leaders, the AHA, representing roughly 5,000 hospitals and clinicians,...
Patients Facing Barriers to Care Most Likely to Be No-Shows
A scoping review of 22 U.S. dermatology studies identified young age, minority race/ethnicity, lack of insurance and limited English proficiency as the strongest predictors of patient no‑shows. Adults 19‑25 were 2.3 times more likely to miss appointments, while Black and Hispanic...
CDC Reports 7 More Unvaccinated Child Flu Deaths
#Flu season is over but #CDC was alerted last wk to 7 more kids who died from flu. Six were from this past season, bringing the total to date to 155. It will grow becoz these deaths are often reported...
Acelyrin Founder Shao-Lee Lin Emerges at Cue, as It Becomes Latest to License From China
Cue Biopharma announced a strategic reboot, appointing Acelyrin founder Shao‑Lee Lin to its executive team and unveiling a new allergy drug candidate sourced from research labs in Taiwan and mainland China. The Boston‑based company, previously focused on T‑cell immunotherapies, will...
Asembia AXS26: How CGTs Are Reshaping Specialty Pharmacy
Cell and gene therapies (CGTs) are fundamentally changing the specialty pharmacy landscape, moving beyond traditional buy‑and‑bill models toward highly coordinated, patient‑specific workflows. The therapies demand specialized treatment‑center activities such as apheresis, conditioning, and strict cold‑chain logistics. High upfront costs create...
Aster DM Targets 15,000 Beds by FY30 Post Merger with Quality Care
Aster DM Healthcare is finalizing its merger with Blackstone‑backed Quality Care by the end of June 2026. The combined company plans to boost its operating margin from the current 21% to roughly 23‑24% within three years. Management projects adding over...
Save the Date: Premium Subscriber-Exclusive Post-Hoc Live
Endpoints News announced a premium‑only Post‑Hoc Live event that will break down Q1 earnings after a deal‑heavy first quarter. The live session promises real‑time analysis, interactive Q&A with analysts, and deeper insight into the companies that drove the quarter’s performance....
How BJC HealthCare Got Better at Advanced Care Planning Discussions
BJC HealthCare, a 14‑hospital system, built a machine‑learning algorithm to flag patients at high risk of dying within 30 days and trigger opt‑out advanced care planning (ACP) conversations. By standardizing provider training and embedding the workflow across inpatient, ICU, primary‑care...
Q&A: AI Platform Targets Clinical Chart Insights Beyond LLM Limits
Dyania Health’s Synapsis AI platform tackles clinical chart review by answering precise, context‑driven questions rather than producing generic summaries. The system was built on roughly 25,000 physician‑annotated hours and is designed to surface nuanced signals for care decisions, trial eligibility, and...
China Never Actually Removed Homosexuality From Its Official List of Mental Disorders
The article debunks the long‑held belief that China removed homosexuality from its official mental‑disorder list in 2001. In fact, the Chinese Classification of Mental Disorders‑3 (CCMD‑3) retained "homosexuality" as a diagnosis, labeling it "not necessarily abnormal" while still allowing conversion‑therapy...
The 'Broken Handoff' Leaving Retirees Lost on Medicare Choices
Retirees exiting employer‑sponsored health plans often receive only a COBRA notice, leaving a "broken handoff" to Medicare advisers. Without coordinated guidance, many miss the initial enrollment window, incurring lifelong premium penalties and suboptimal plan choices. The issue affects roughly 10,000...
RA/QA News Roll: Late April 2026
The FDA saw a leadership shuffle as Principal Deputy Commissioner Sara Brenner moved to a senior HHS counseling role, while Commissioner Robert Makary pushed a bold agenda to fast‑track psychedelic therapies, issuing three new National Priority Vouchers and signing an...
OP-3136
OP‑3136, a KAT6A‑selective inhibitor, entered Phase 1/2 trials for advanced hormone‑receptor‑positive breast cancer. The drug mimics the pyrophosphate of acetyl‑CoA using an acyl‑sulfonamide scaffold, delivering high specificity for the epigenetic writer KAT6A. Olema Pharmaceuticals is testing OP‑3136 in combination with SERDs...
Microbiome-Based Therapy Gains FDA Fast Track in Ulcerative Colitis
Belgium‑based MRM Health announced that its investigational microbiome‑based therapy MH002 has been granted FDA fast track designation for mild‑to‑moderate ulcerative colitis. MH002 is a live biotherapeutic composed of six defined commensal bacterial strains designed to restore gut microbial balance and...
The Biggest Drug Dealers Have Always Worn Suits
A federal judge ordered the dissolution of Purdue Pharma, replacing it with a new entity called Knoa Pharma, while the Sackler family agreed to pay up to $7 billion over 15 years. The settlement offers individual victims $8,000‑$16,000 per claim for...
CAQH Index Finds $20 Billion in Cost Savings Opportunities
The 2025 CAQH Index, which surveys 600 provider organizations covering 63% of insured lives, estimates over $20 billion in cost‑saving opportunities if automation of medical and dental workflows is expanded. Electronic prior‑authorization adoption rose to 40%, while other electronic processes remained...
From Resistance Training to Robotic Surgery, New ASBrS Research Points Toward More Personalized Breast Cancer Care
Four studies presented at the American Society of Breast Surgeons meeting highlight a shift toward less invasive, patient‑centered breast cancer care. A three‑month supervised resistance‑training program boosted strength and body composition across lumpectomy, mastectomy and axillary‑dissection patients. Data showed that...
Ardent Health to Participate in the Bank of America 2026 Healthcare Conference
Ardent Health (NYSE: ARDT) announced it will take part in the Bank of America 2026 Healthcare Conference on May 13 in Las Vegas. The company’s senior leadership will appear in a fireside chat at 11:00 a.m. ET, with the session streamed...
Sydnexis to Present New Data From Phase 3 STAR Trial of SYD-101 at ARVO 2026 Annual Meeting
Sydnexis announced it will unveil new subgroup analysis data from the Phase 3 STAR trial of its low‑dose atropine eye drop SYD‑101 at the ARVO 2026 meeting in Denver. The analysis focuses on children with fast‑progressing myopia, a cohort that typically...
Elevance Health Names Best in Class Primary Care Practices in Care Provider Recognition Program
Elevance Health announced its annual Care Provider Recognition Program, honoring 45 medical practices and health systems that rank in the top one percent of its roughly 7,200 value‑based care partners. The award spotlights primary‑care providers delivering superior preventive screenings, immunizations,...
FDP, Palantir and Global Counsel: Under Mandelson's Long Shadow
The NHS’s Federated Data Platform (FDP) was awarded to US data‑analytics firm Palantir in 2023. A letter highlights that Palantir hired Global Counsel, a lobbying firm co‑founded by former Labour minister Peter Mandelson, who was recently dismissed as the UK’s ambassador...
AI Access Gaps Persist: Lower‑SES Americans Less Aware, Use Less
A study of >10,000 Americans documents AI inequalities, lack of awareness and usage among lower SES https://t.co/1s8EMg933Y https://t.co/6BA6p7g2zW
Wall Street Sees BMY Lift, BIIB Rise, REGN Uncertainty
Latest snapshot of Wall Street's take on a trio of earnings reports, from @ByJonGardner and @realJacobBell Bristol Myers’ legacy lift, Biogen’s blue skies and Regeneron’s murky outlook https://t.co/PnGb0o93WL $BIIB $BMY $REGN
World Asthma Day 2026: New Anti-Inflammatory Drugs and More for Asthma Control
World Asthma Day on May 5 highlighted the persistent gap in access to anti‑inflammatory inhalers, a core theme of the Global Initiative for Asthma. The FDA approved AstraZeneca’s Breztri Aerosphere, the first single‑inhaler triple therapy that combines an inhaled corticosteroid, a...
2026 Measles Cases Surge to 79% of 2025 Total
#Measles update: In the first 4 months of 2026, there have been 1,814 confirmed measles cases (& doubtless many more that were never confirmed). For context: That's 79% of the total for the entirety of 2025 — but in 4 months,...
Non-Tobacco Nicotine Products Tied to Pregnancy, Labor Complications
A multi‑institutional study of 77,549 pregnant patients presented at the ACOG meeting found that non‑tobacco nicotine use—primarily vaping and nicotine pouches—significantly raises the risk of adverse pregnancy outcomes, including preterm labor, cesarean delivery, and maternal death. Relative risks ranged from...
GLP-1 Pills Are Here: Can Employers Afford to Cover Weight-Loss Drugs?
Oral GLP‑1 weight‑loss pills are entering the market as employers grapple with whether to add them to health benefits. A 2025 KFF survey shows only 19% of firms with 200+ workers covered GLP‑1s, but coverage jumps to 43% among companies...
How Expert Radiology Scaled a National Teleradiology Practice
Expert Radiology Management Services, founded in 2020, has built a national subspecialty teleradiology network that now spans all 50 states, 350+ imaging facilities, and a 26‑physician team. By adopting RamSoft’s PowerServer with PowerReader, the practice achieved sub‑6‑second study loading and...
New Semaglutide for Alcohol Use Disorder Trial Shows Big Drops in Drinking
A Lancet‑published, double‑blind, 26‑week trial found once‑weekly semaglutide markedly reduced alcohol consumption in participants with alcohol use disorder and obesity. Across primary drinking endpoints, the semaglutide arm showed statistically significant declines compared with placebo, despite both groups receiving identical cognitive‑behavioral...
Syngene Sees Pipeline Traction, Bets on Biologics for Growth Beyond FY27
Syngene International posted a modest 2% revenue rise to ₹1,037 crore (~$125 m) in Q4 FY26, while profit after tax fell 16% to ₹153 crore (~$18 m) due to exceptional costs and a key biologics client’s destocking. Margins compressed, with EBITDA margin dropping to...
Arrowhead Pharmaceuticals Receives TGA Approval of REDEMPLO® (Plozasiran) in Australia, Expanding Global Access for Patients with Familial Chylomicronemia Syndrome (FCS)
Arrowhead Pharmaceuticals announced that Australia’s Therapeutic Goods Administration approved REDEMPLO® (plozasiran), the first siRNA therapy for familial chylomicronemia syndrome (FCS) in the country. The drug, administered subcutaneously every three months, targets apoC‑III to dramatically lower triglycerides. In the Phase 3 PALISADE...
Moderna Beats Revenue Expectations with $389M, but Litigation Dogs Earnings
Moderna reported first‑quarter revenue of $389 million, roughly 50% above analysts’ expectations, while vaccine sales reached $352 million, beating consensus. A $950 million upfront settlement with Arbutus over lipid‑nanoparticle patents pushed the net loss to $1.3 billion, though it was still better than the...
Cycling for Weight Loss: GLP-1s
GLP‑1 medications like Wegovy and Ozempic are increasingly used for weight loss, but they can blunt hunger and thirst signals, making proper fueling critical for cyclists. Bicycling’s guide, hosted by Ryan Grewell and nutritionist Namrita Brooke, outlines how to combine...
‘A Powerful Tool for Respect’: Birth Plans Improve Maternal, Neonatal Outcomes
A systematic review and meta‑analysis presented at the ACOG annual meeting found that birth plans significantly improve maternal and neonatal outcomes. Women with a birth plan were over three times more likely to have a spontaneous vaginal delivery and to...